Green D
Department of Dermatology, Howard University Hospital, Washington, DC, USA.
Ophthalmology. 2001 Mar;108(3):442-8. doi: 10.1016/s0161-6420(00)00384-5.
Prominent periocular veins, especially of the lower eyelid, are not uncommon and patients often seek their removal. Sclerotherapy is a procedure that has been successfully used to permanently remove varicose and telangiectatic veins of the lower extremity and less frequently at other sites. Although it has been successfully used to remove dilated facial veins, it is seldom performed and often not recommended in the periocular region for fear of complications occurring in adjacent structures. The purpose of this study was to determine whether sclerotherapy could safely and effectively eradicate prominent periocular veins.
Noncomparative case series.
Fifty adult female patients with prominent periocular veins in the lower eyelid were treated unilaterally.
Sclerotherapy was performed with a 0.75% solution of sodium tetradecyl sulfate. All patients were followed for at least 12 months after treatment.
Complete clinical disappearance of the treated vein was the criterion for success.
All 50 patients were successfully treated with uneventful resorption of their ectatic periocular veins. No patient required a second treatment and there was no evidence of treatment failure at 12 months. No new veins developed at the treated sites and no patient experienced any ophthalmologic or neurologic side effects or complications.
Sclerotherapy appears to be a safe and effective means of permanently eradicating periocular veins.
眼周静脉突出，尤其是下眼睑静脉突出并不罕见，患者常寻求去除。硬化疗法已成功用于永久性去除下肢静脉曲张和毛细血管扩张性静脉，在其他部位使用较少。尽管它已成功用于去除扩张的面部静脉，但在眼周区域很少进行，且由于担心邻近结构出现并发症，通常不被推荐。本研究的目的是确定硬化疗法能否安全有效地消除眼周突出静脉。
非对照病例系列。
50例下眼睑眼周静脉突出的成年女性患者接受单侧治疗。
用0.75%的十四烷基硫酸钠溶液进行硬化疗法。所有患者在治疗后至少随访12个月。
治疗静脉完全临床消失为成功标准。
所有50例患者均成功治疗，扩张的眼周静脉顺利吸收。无患者需要二次治疗，且在12个月时无治疗失败的证据。治疗部位未出现新的静脉，无患者出现任何眼科或神经科副作用或并发症。
硬化疗法似乎是永久消除眼周静脉的一种安全有效的方法。
